nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ABCB1—Lisinopril—systemic scleroderma	0.0498	0.189	CbGbCtD
Risperidone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0451	0.171	CbGbCtD
Risperidone—ABCB1—Captopril—systemic scleroderma	0.0373	0.141	CbGbCtD
Risperidone—CYP2D6—Captopril—systemic scleroderma	0.0351	0.133	CbGbCtD
Risperidone—HTR2B—cardial valve—systemic scleroderma	0.0305	0.2	CbGeAlD
Risperidone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0293	0.111	CbGbCtD
Risperidone—ABCB1—Prednisone—systemic scleroderma	0.0235	0.0891	CbGbCtD
Risperidone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0176	0.0667	CbGbCtD
Risperidone—HTR7—myenteric nerve plexus—systemic scleroderma	0.0149	0.0979	CbGeAlD
Risperidone—CYP3A4—Prednisone—systemic scleroderma	0.0141	0.0534	CbGbCtD
Risperidone—ABCB1—Methotrexate—systemic scleroderma	0.0118	0.0447	CbGbCtD
Risperidone—HTR7—pulmonary artery—systemic scleroderma	0.0106	0.0693	CbGeAlD
Risperidone—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0093	0.061	CbGeAlD
Risperidone—HTR2A—pulmonary artery—systemic scleroderma	0.00659	0.0432	CbGeAlD
Risperidone—HTR1B—artery—systemic scleroderma	0.00508	0.0333	CbGeAlD
Risperidone—HTR1D—artery—systemic scleroderma	0.00492	0.0323	CbGeAlD
Risperidone—HTR1B—blood vessel—systemic scleroderma	0.00396	0.026	CbGeAlD
Risperidone—HTR7—artery—systemic scleroderma	0.00392	0.0257	CbGeAlD
Risperidone—HTR1D—blood vessel—systemic scleroderma	0.00383	0.0251	CbGeAlD
Risperidone—HTR7—endothelium—systemic scleroderma	0.00331	0.0217	CbGeAlD
Risperidone—HTR7—blood vessel—systemic scleroderma	0.00305	0.02	CbGeAlD
Risperidone—H1F0—connective tissue—systemic scleroderma	0.00253	0.0166	CbGeAlD
Risperidone—HTR2A—artery—systemic scleroderma	0.00244	0.016	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—systemic scleroderma	0.00232	0.0152	CbGeAlD
Risperidone—H1F0—skin of body—systemic scleroderma	0.00229	0.015	CbGeAlD
Risperidone—HTR2A—endothelium—systemic scleroderma	0.00206	0.0135	CbGeAlD
Risperidone—HTR1D—connective tissue—systemic scleroderma	0.00196	0.0129	CbGeAlD
Risperidone—HTR2A—blood vessel—systemic scleroderma	0.0019	0.0125	CbGeAlD
Risperidone—H1F0—digestive system—systemic scleroderma	0.00183	0.012	CbGeAlD
Risperidone—H1F0—tendon—systemic scleroderma	0.00174	0.0114	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—systemic scleroderma	0.00167	0.011	CbGeAlD
Risperidone—HTR2B—skin of body—systemic scleroderma	0.00165	0.0108	CbGeAlD
Risperidone—HTR7—connective tissue—systemic scleroderma	0.00156	0.0103	CbGeAlD
Risperidone—H1F0—lung—systemic scleroderma	0.00153	0.01	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—systemic scleroderma	0.00143	0.00939	CbGeAlD
Risperidone—HTR2B—digestive system—systemic scleroderma	0.00132	0.00865	CbGeAlD
Risperidone—HTR2B—tendon—systemic scleroderma	0.00126	0.00824	CbGeAlD
Risperidone—ABCB1—blood vessel—systemic scleroderma	0.00125	0.00818	CbGeAlD
Risperidone—HRH1—connective tissue—systemic scleroderma	0.00117	0.00766	CbGeAlD
Risperidone—ADRA2A—connective tissue—systemic scleroderma	0.00115	0.00753	CbGeAlD
Risperidone—HTR7—digestive system—systemic scleroderma	0.00113	0.00741	CbGeAlD
Risperidone—HTR2B—lung—systemic scleroderma	0.0011	0.00723	CbGeAlD
Risperidone—HTR7—tendon—systemic scleroderma	0.00108	0.00705	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—systemic scleroderma	0.00107	0.00701	CbGeAlD
Risperidone—ADRA2C—tendon—systemic scleroderma	0.000988	0.00648	CbGeAlD
Risperidone—HTR2A—connective tissue—systemic scleroderma	0.000975	0.0064	CbGeAlD
Risperidone—HTR7—lung—systemic scleroderma	0.000943	0.00619	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—systemic scleroderma	0.000892	0.00585	CbGeAlD
Risperidone—DRD2—lung—systemic scleroderma	0.000892	0.00585	CbGeAlD
Risperidone—CYP3A5—digestive system—systemic scleroderma	0.000869	0.0057	CbGeAlD
Risperidone—ADRA2C—lung—systemic scleroderma	0.000867	0.00569	CbGeAlD
Risperidone—HRH1—digestive system—systemic scleroderma	0.000843	0.00553	CbGeAlD
Risperidone—HRH1—tendon—systemic scleroderma	0.000803	0.00527	CbGeAlD
Risperidone—ADRA2A—tendon—systemic scleroderma	0.000788	0.00517	CbGeAlD
Risperidone—CYP3A5—lung—systemic scleroderma	0.000726	0.00476	CbGeAlD
Risperidone—HTR2A—digestive system—systemic scleroderma	0.000704	0.00462	CbGeAlD
Risperidone—HRH1—lung—systemic scleroderma	0.000704	0.00462	CbGeAlD
Risperidone—ADRA2A—lung—systemic scleroderma	0.000692	0.00454	CbGeAlD
Risperidone—HTR2A—tendon—systemic scleroderma	0.00067	0.0044	CbGeAlD
Risperidone—CYP3A4—digestive system—systemic scleroderma	0.000652	0.00428	CbGeAlD
Risperidone—CYP2D6—digestive system—systemic scleroderma	0.000642	0.00421	CbGeAlD
Risperidone—HTR2A—lung—systemic scleroderma	0.000588	0.00386	CbGeAlD
Risperidone—ABCB1—digestive system—systemic scleroderma	0.000462	0.00303	CbGeAlD
Risperidone—ABCB1—lung—systemic scleroderma	0.000386	0.00253	CbGeAlD
Risperidone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000181	0.00031	CcSEcCtD
Risperidone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000181	0.00031	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00031	CcSEcCtD
Risperidone—Insomnia—Lisinopril—systemic scleroderma	0.00018	0.000308	CcSEcCtD
Risperidone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000308	CcSEcCtD
Risperidone—Paraesthesia—Lisinopril—systemic scleroderma	0.000179	0.000306	CcSEcCtD
Risperidone—Vomiting—Captopril—systemic scleroderma	0.000179	0.000306	CcSEcCtD
Risperidone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000305	CcSEcCtD
Risperidone—Dyspnoea—Lisinopril—systemic scleroderma	0.000178	0.000304	CcSEcCtD
Risperidone—Rash—Captopril—systemic scleroderma	0.000177	0.000304	CcSEcCtD
Risperidone—Dermatitis—Captopril—systemic scleroderma	0.000177	0.000303	CcSEcCtD
Risperidone—Somnolence—Lisinopril—systemic scleroderma	0.000177	0.000303	CcSEcCtD
Risperidone—Headache—Captopril—systemic scleroderma	0.000176	0.000302	CcSEcCtD
Risperidone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000301	CcSEcCtD
Risperidone—Dyspepsia—Lisinopril—systemic scleroderma	0.000175	0.0003	CcSEcCtD
Risperidone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000175	0.000299	CcSEcCtD
Risperidone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000175	0.000299	CcSEcCtD
Risperidone—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000299	CcSEcCtD
Risperidone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000299	CcSEcCtD
Risperidone—Asthma—Methotrexate—systemic scleroderma	0.000174	0.000298	CcSEcCtD
Risperidone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000297	CcSEcCtD
Risperidone—Decreased appetite—Lisinopril—systemic scleroderma	0.000173	0.000296	CcSEcCtD
Risperidone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000172	0.000294	CcSEcCtD
Risperidone—Fatigue—Lisinopril—systemic scleroderma	0.000172	0.000294	CcSEcCtD
Risperidone—Shock—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000294	CcSEcCtD
Risperidone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000293	CcSEcCtD
Risperidone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000293	CcSEcCtD
Risperidone—Hypersensitivity—Leflunomide—systemic scleroderma	0.000171	0.000292	CcSEcCtD
Risperidone—Pancreatitis—Methotrexate—systemic scleroderma	0.00017	0.000292	CcSEcCtD
Risperidone—Pain—Lisinopril—systemic scleroderma	0.00017	0.000292	CcSEcCtD
Risperidone—Constipation—Lisinopril—systemic scleroderma	0.00017	0.000292	CcSEcCtD
Risperidone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000292	CcSEcCtD
Risperidone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00029	CcSEcCtD
Risperidone—Bradycardia—Prednisone—systemic scleroderma	0.00017	0.00029	CcSEcCtD
Risperidone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000289	CcSEcCtD
Risperidone—Diarrhoea—Azathioprine—systemic scleroderma	0.000168	0.000288	CcSEcCtD
Risperidone—Haemoglobin—Prednisone—systemic scleroderma	0.000167	0.000287	CcSEcCtD
Risperidone—Nausea—Captopril—systemic scleroderma	0.000167	0.000286	CcSEcCtD
Risperidone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000167	0.000285	CcSEcCtD
Risperidone—Haemorrhage—Prednisone—systemic scleroderma	0.000167	0.000285	CcSEcCtD
Risperidone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000285	CcSEcCtD
Risperidone—Asthenia—Leflunomide—systemic scleroderma	0.000166	0.000285	CcSEcCtD
Risperidone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000164	0.000281	CcSEcCtD
Risperidone—Pruritus—Leflunomide—systemic scleroderma	0.000164	0.000281	CcSEcCtD
Risperidone—Connective tissue disorder—Prednisone—systemic scleroderma	0.000164	0.00028	CcSEcCtD
Risperidone—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000279	CcSEcCtD
Risperidone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000163	0.000279	CcSEcCtD
Risperidone—Dysuria—Methotrexate—systemic scleroderma	0.000163	0.000278	CcSEcCtD
Risperidone—Neutropenia—Methotrexate—systemic scleroderma	0.000163	0.000278	CcSEcCtD
Risperidone—Dizziness—Azathioprine—systemic scleroderma	0.000162	0.000278	CcSEcCtD
Risperidone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000162	0.000277	CcSEcCtD
Risperidone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00016	0.000274	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000272	CcSEcCtD
Risperidone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000159	0.000272	CcSEcCtD
Risperidone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000159	0.000272	CcSEcCtD
Risperidone—Diarrhoea—Leflunomide—systemic scleroderma	0.000159	0.000272	CcSEcCtD
Risperidone—Urticaria—Lisinopril—systemic scleroderma	0.000158	0.000271	CcSEcCtD
Risperidone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00027	CcSEcCtD
Risperidone—Abdominal pain—Lisinopril—systemic scleroderma	0.000157	0.00027	CcSEcCtD
Risperidone—Body temperature increased—Lisinopril—systemic scleroderma	0.000157	0.00027	CcSEcCtD
Risperidone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000268	CcSEcCtD
Risperidone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000156	0.000268	CcSEcCtD
Risperidone—Vomiting—Azathioprine—systemic scleroderma	0.000156	0.000267	CcSEcCtD
Risperidone—Pneumonia—Methotrexate—systemic scleroderma	0.000156	0.000267	CcSEcCtD
Risperidone—Eye disorder—Prednisone—systemic scleroderma	0.000156	0.000266	CcSEcCtD
Risperidone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000266	CcSEcCtD
Risperidone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000266	CcSEcCtD
Risperidone—Infestation NOS—Methotrexate—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Drowsiness—Methotrexate—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Infestation—Methotrexate—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Rash—Azathioprine—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Dermatitis—Azathioprine—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Depression—Methotrexate—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Flushing—Prednisone—systemic scleroderma	0.000155	0.000265	CcSEcCtD
Risperidone—Headache—Azathioprine—systemic scleroderma	0.000154	0.000263	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000154	0.000263	CcSEcCtD
Risperidone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000263	CcSEcCtD
Risperidone—Dizziness—Leflunomide—systemic scleroderma	0.000153	0.000262	CcSEcCtD
Risperidone—Renal failure—Methotrexate—systemic scleroderma	0.000152	0.000261	CcSEcCtD
Risperidone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00026	CcSEcCtD
Risperidone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000151	0.000259	CcSEcCtD
Risperidone—Stomatitis—Methotrexate—systemic scleroderma	0.000151	0.000259	CcSEcCtD
Risperidone—Angiopathy—Prednisone—systemic scleroderma	0.000151	0.000259	CcSEcCtD
Risperidone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000151	0.000258	CcSEcCtD
Risperidone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000258	CcSEcCtD
Risperidone—Immune system disorder—Prednisone—systemic scleroderma	0.00015	0.000258	CcSEcCtD
Risperidone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000256	CcSEcCtD
Risperidone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000256	CcSEcCtD
Risperidone—Arrhythmia—Prednisone—systemic scleroderma	0.000149	0.000255	CcSEcCtD
Risperidone—Sweating—Methotrexate—systemic scleroderma	0.000149	0.000254	CcSEcCtD
Risperidone—Haematuria—Methotrexate—systemic scleroderma	0.000148	0.000253	CcSEcCtD
Risperidone—Vomiting—Leflunomide—systemic scleroderma	0.000147	0.000252	CcSEcCtD
Risperidone—Alopecia—Prednisone—systemic scleroderma	0.000147	0.000252	CcSEcCtD
Risperidone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000147	0.000251	CcSEcCtD
Risperidone—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000147	0.000251	CcSEcCtD
Risperidone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Epistaxis—Methotrexate—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Rash—Leflunomide—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Dermatitis—Leflunomide—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Mental disorder—Prednisone—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Nausea—Azathioprine—systemic scleroderma	0.000146	0.00025	CcSEcCtD
Risperidone—Headache—Leflunomide—systemic scleroderma	0.000145	0.000249	CcSEcCtD
Risperidone—Malnutrition—Prednisone—systemic scleroderma	0.000145	0.000248	CcSEcCtD
Risperidone—Erythema—Prednisone—systemic scleroderma	0.000145	0.000248	CcSEcCtD
Risperidone—Agranulocytosis—Methotrexate—systemic scleroderma	0.000145	0.000248	CcSEcCtD
Risperidone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000246	CcSEcCtD
Risperidone—Asthenia—Lisinopril—systemic scleroderma	0.000143	0.000245	CcSEcCtD
Risperidone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000244	CcSEcCtD
Risperidone—Pruritus—Lisinopril—systemic scleroderma	0.000141	0.000241	CcSEcCtD
Risperidone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000141	0.000241	CcSEcCtD
Risperidone—Haemoglobin—Methotrexate—systemic scleroderma	0.00014	0.000239	CcSEcCtD
Risperidone—Rash—Mycophenolic acid—systemic scleroderma	0.000139	0.000239	CcSEcCtD
Risperidone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000139	0.000239	CcSEcCtD
Risperidone—Haemorrhage—Methotrexate—systemic scleroderma	0.000139	0.000238	CcSEcCtD
Risperidone—Hepatitis—Methotrexate—systemic scleroderma	0.000139	0.000238	CcSEcCtD
Risperidone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000237	CcSEcCtD
Risperidone—Headache—Mycophenolic acid—systemic scleroderma	0.000139	0.000237	CcSEcCtD
Risperidone—Pharyngitis—Methotrexate—systemic scleroderma	0.000138	0.000236	CcSEcCtD
Risperidone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000236	CcSEcCtD
Risperidone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000236	CcSEcCtD
Risperidone—Nausea—Leflunomide—systemic scleroderma	0.000138	0.000236	CcSEcCtD
Risperidone—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000137	0.000235	CcSEcCtD
Risperidone—Vision blurred—Prednisone—systemic scleroderma	0.000137	0.000234	CcSEcCtD
Risperidone—Urethral disorder—Methotrexate—systemic scleroderma	0.000136	0.000234	CcSEcCtD
Risperidone—Diarrhoea—Lisinopril—systemic scleroderma	0.000136	0.000233	CcSEcCtD
Risperidone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000135	0.00023	CcSEcCtD
Risperidone—Visual impairment—Methotrexate—systemic scleroderma	0.000134	0.00023	CcSEcCtD
Risperidone—Anaemia—Prednisone—systemic scleroderma	0.000134	0.000229	CcSEcCtD
Risperidone—Agitation—Prednisone—systemic scleroderma	0.000133	0.000228	CcSEcCtD
Risperidone—Angioedema—Prednisone—systemic scleroderma	0.000132	0.000227	CcSEcCtD
Risperidone—Dizziness—Lisinopril—systemic scleroderma	0.000132	0.000226	CcSEcCtD
Risperidone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000132	0.000225	CcSEcCtD
Risperidone—Nausea—Mycophenolic acid—systemic scleroderma	0.000131	0.000225	CcSEcCtD
Risperidone—Malaise—Prednisone—systemic scleroderma	0.000131	0.000224	CcSEcCtD
Risperidone—Vertigo—Prednisone—systemic scleroderma	0.00013	0.000223	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—systemic scleroderma	0.00013	0.000223	CcSEcCtD
Risperidone—Syncope—Prednisone—systemic scleroderma	0.00013	0.000223	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—systemic scleroderma	0.00013	0.000222	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—systemic scleroderma	0.000129	0.000221	CcSEcCtD
Risperidone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00022	CcSEcCtD
Risperidone—Loss of consciousness—Prednisone—systemic scleroderma	0.000127	0.000218	CcSEcCtD
Risperidone—Vomiting—Lisinopril—systemic scleroderma	0.000127	0.000217	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—systemic scleroderma	0.000126	0.000216	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—systemic scleroderma	0.000126	0.000215	CcSEcCtD
Risperidone—Rash—Lisinopril—systemic scleroderma	0.000126	0.000215	CcSEcCtD
Risperidone—Convulsion—Prednisone—systemic scleroderma	0.000126	0.000215	CcSEcCtD
Risperidone—Dermatitis—Lisinopril—systemic scleroderma	0.000125	0.000215	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000125	0.000215	CcSEcCtD
Risperidone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000214	CcSEcCtD
Risperidone—Hypertension—Prednisone—systemic scleroderma	0.000125	0.000214	CcSEcCtD
Risperidone—Chills—Methotrexate—systemic scleroderma	0.000125	0.000214	CcSEcCtD
Risperidone—Headache—Lisinopril—systemic scleroderma	0.000125	0.000214	CcSEcCtD
Risperidone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000211	CcSEcCtD
Risperidone—Arthralgia—Prednisone—systemic scleroderma	0.000123	0.000211	CcSEcCtD
Risperidone—Myalgia—Prednisone—systemic scleroderma	0.000123	0.000211	CcSEcCtD
Risperidone—Anxiety—Prednisone—systemic scleroderma	0.000123	0.000211	CcSEcCtD
Risperidone—Alopecia—Methotrexate—systemic scleroderma	0.000123	0.000211	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000123	0.00021	CcSEcCtD
Risperidone—Discomfort—Prednisone—systemic scleroderma	0.000122	0.000209	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—systemic scleroderma	0.000122	0.000209	CcSEcCtD
Risperidone—Erythema—Methotrexate—systemic scleroderma	0.000121	0.000207	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—systemic scleroderma	0.000121	0.000207	CcSEcCtD
Risperidone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000204	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—systemic scleroderma	0.000119	0.000203	CcSEcCtD
Risperidone—Nausea—Lisinopril—systemic scleroderma	0.000118	0.000203	CcSEcCtD
Risperidone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000118	0.000203	CcSEcCtD
Risperidone—Oedema—Prednisone—systemic scleroderma	0.000118	0.000203	CcSEcCtD
Risperidone—Infection—Prednisone—systemic scleroderma	0.000118	0.000201	CcSEcCtD
Risperidone—Back pain—Methotrexate—systemic scleroderma	0.000117	0.000201	CcSEcCtD
Risperidone—Shock—Prednisone—systemic scleroderma	0.000116	0.000199	CcSEcCtD
Risperidone—Nervous system disorder—Prednisone—systemic scleroderma	0.000116	0.000199	CcSEcCtD
Risperidone—Tachycardia—Prednisone—systemic scleroderma	0.000115	0.000198	CcSEcCtD
Risperidone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000115	0.000198	CcSEcCtD
Risperidone—Skin disorder—Prednisone—systemic scleroderma	0.000115	0.000197	CcSEcCtD
Risperidone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000114	0.000196	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—systemic scleroderma	0.000114	0.000195	CcSEcCtD
Risperidone—Anorexia—Prednisone—systemic scleroderma	0.000113	0.000193	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000112	0.000192	CcSEcCtD
Risperidone—Anaemia—Methotrexate—systemic scleroderma	0.000112	0.000192	CcSEcCtD
Risperidone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000111	0.00019	CcSEcCtD
Risperidone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000188	CcSEcCtD
Risperidone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000188	CcSEcCtD
Risperidone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000187	CcSEcCtD
Risperidone—Malaise—Methotrexate—systemic scleroderma	0.000109	0.000187	CcSEcCtD
Risperidone—Vertigo—Methotrexate—systemic scleroderma	0.000109	0.000186	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—systemic scleroderma	0.000108	0.000186	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000108	0.000185	CcSEcCtD
Risperidone—Insomnia—Prednisone—systemic scleroderma	0.000107	0.000183	CcSEcCtD
Risperidone—Paraesthesia—Prednisone—systemic scleroderma	0.000106	0.000182	CcSEcCtD
Risperidone—Cough—Methotrexate—systemic scleroderma	0.000106	0.000181	CcSEcCtD
Risperidone—Convulsion—Methotrexate—systemic scleroderma	0.000105	0.00018	CcSEcCtD
Risperidone—Dyspepsia—Prednisone—systemic scleroderma	0.000104	0.000178	CcSEcCtD
Risperidone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000177	CcSEcCtD
Risperidone—Myalgia—Methotrexate—systemic scleroderma	0.000103	0.000177	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—systemic scleroderma	0.000103	0.000177	CcSEcCtD
Risperidone—Chest pain—Methotrexate—systemic scleroderma	0.000103	0.000177	CcSEcCtD
Risperidone—Decreased appetite—Prednisone—systemic scleroderma	0.000103	0.000176	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000102	0.000175	CcSEcCtD
Risperidone—Fatigue—Prednisone—systemic scleroderma	0.000102	0.000175	CcSEcCtD
Risperidone—Discomfort—Methotrexate—systemic scleroderma	0.000102	0.000174	CcSEcCtD
Risperidone—Constipation—Prednisone—systemic scleroderma	0.000101	0.000173	CcSEcCtD
Risperidone—Confusional state—Methotrexate—systemic scleroderma	9.97e-05	0.000171	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—systemic scleroderma	9.89e-05	0.000169	CcSEcCtD
Risperidone—Infection—Methotrexate—systemic scleroderma	9.82e-05	0.000168	CcSEcCtD
Risperidone—Feeling abnormal—Prednisone—systemic scleroderma	9.75e-05	0.000167	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—systemic scleroderma	9.7e-05	0.000166	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—systemic scleroderma	9.68e-05	0.000166	CcSEcCtD
Risperidone—Gastrointestinal pain—Prednisone—systemic scleroderma	9.68e-05	0.000166	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—systemic scleroderma	9.6e-05	0.000164	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—systemic scleroderma	9.56e-05	0.000164	CcSEcCtD
Risperidone—Anorexia—Methotrexate—systemic scleroderma	9.43e-05	0.000161	CcSEcCtD
Risperidone—Urticaria—Prednisone—systemic scleroderma	9.4e-05	0.000161	CcSEcCtD
Risperidone—Abdominal pain—Prednisone—systemic scleroderma	9.35e-05	0.00016	CcSEcCtD
Risperidone—Body temperature increased—Prednisone—systemic scleroderma	9.35e-05	0.00016	CcSEcCtD
Risperidone—Hypotension—Methotrexate—systemic scleroderma	9.24e-05	0.000158	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	9.01e-05	0.000154	CcSEcCtD
Risperidone—Insomnia—Methotrexate—systemic scleroderma	8.94e-05	0.000153	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—systemic scleroderma	8.88e-05	0.000152	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—systemic scleroderma	8.82e-05	0.000151	CcSEcCtD
Risperidone—Somnolence—Methotrexate—systemic scleroderma	8.79e-05	0.00015	CcSEcCtD
Risperidone—Hypersensitivity—Prednisone—systemic scleroderma	8.72e-05	0.000149	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—systemic scleroderma	8.7e-05	0.000149	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—systemic scleroderma	8.6e-05	0.000147	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.54e-05	0.000146	CcSEcCtD
Risperidone—Fatigue—Methotrexate—systemic scleroderma	8.53e-05	0.000146	CcSEcCtD
Risperidone—Asthenia—Prednisone—systemic scleroderma	8.49e-05	0.000145	CcSEcCtD
Risperidone—Pain—Methotrexate—systemic scleroderma	8.46e-05	0.000145	CcSEcCtD
Risperidone—Pruritus—Prednisone—systemic scleroderma	8.37e-05	0.000143	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—systemic scleroderma	8.15e-05	0.000139	CcSEcCtD
Risperidone—Diarrhoea—Prednisone—systemic scleroderma	8.1e-05	0.000139	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.09e-05	0.000138	CcSEcCtD
Risperidone—Urticaria—Methotrexate—systemic scleroderma	7.86e-05	0.000134	CcSEcCtD
Risperidone—Dizziness—Prednisone—systemic scleroderma	7.82e-05	0.000134	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—systemic scleroderma	7.82e-05	0.000134	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—systemic scleroderma	7.82e-05	0.000134	CcSEcCtD
Risperidone—Vomiting—Prednisone—systemic scleroderma	7.52e-05	0.000129	CcSEcCtD
Risperidone—Rash—Prednisone—systemic scleroderma	7.46e-05	0.000128	CcSEcCtD
Risperidone—Dermatitis—Prednisone—systemic scleroderma	7.45e-05	0.000128	CcSEcCtD
Risperidone—Headache—Prednisone—systemic scleroderma	7.41e-05	0.000127	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—systemic scleroderma	7.29e-05	0.000125	CcSEcCtD
Risperidone—Asthenia—Methotrexate—systemic scleroderma	7.09e-05	0.000121	CcSEcCtD
Risperidone—Nausea—Prednisone—systemic scleroderma	7.03e-05	0.00012	CcSEcCtD
Risperidone—Pruritus—Methotrexate—systemic scleroderma	7e-05	0.00012	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—systemic scleroderma	6.77e-05	0.000116	CcSEcCtD
Risperidone—Dizziness—Methotrexate—systemic scleroderma	6.54e-05	0.000112	CcSEcCtD
Risperidone—Vomiting—Methotrexate—systemic scleroderma	6.29e-05	0.000108	CcSEcCtD
Risperidone—Rash—Methotrexate—systemic scleroderma	6.23e-05	0.000107	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—systemic scleroderma	6.23e-05	0.000107	CcSEcCtD
Risperidone—Headache—Methotrexate—systemic scleroderma	6.19e-05	0.000106	CcSEcCtD
Risperidone—Nausea—Methotrexate—systemic scleroderma	5.87e-05	0.000101	CcSEcCtD
